MOG and Peripheral demyelination: In contrast, anti-MOG antibody–positive patients who do relapse are typically offered treatment with immunoglobulins, anti-CD20, or more general immunosuppressive therapies.7,30 Further research is required to confirm whether relapsing MOG demyelination is a lifelong illness and to define the morbidity of seropositive-related relapses more fully.